Biological E Corbevax
- All
- News
- Videos
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Made-In-India Biological E Vaccine May Be 90% Effective, "Game-Changer"
Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Made-In-India Biological E Vaccine May Be 90% Effective, "Game-Changer"
Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.
